Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-26-000007

CHIEF FINANCIAL OFFICER sold 24,001 shares at $1.76 ($42,242)

From the SEC's structured data for this filing

Trades in this filing

Parker Geoffrey M. · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form −24,001 $1.76 $42,242 1,252,795 D
Open-market sales · 24,001 sh · avg $1.76 · $42,242

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 2 in the form Stock Option (Right to buy) +539,072 539,072 D
2026-02-02 Grant or award : show line 3 in the form Restricted Stock Unit +152,480 152,480 D
Loading xslF345X05/wk-form4_1770243376.xml…